First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study

By Papakostas P.   Kouroussis C.   Androulakis N.   Samelis G.   Aravantinos G.   Kalbakis K.   Sarra E.   Souglakos J.   Kakolyris S.   Georgoulias V.  

European Journal of Cancer, Vol. 37, Iss. 15, 2001-10 ,pp. : 1833-1838

Elsevier

Access to resources Recommend Favorite

A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

By Diéras Véronique   Guastalla Jean   Ferrero Jean   Curé Hervé   Weber Béatrice   Winckel Philippe   Lortholary Alain   Mayer Françoise   Paraiso Désiré   Magherini Emmanuelle   Pujade-Lauraine Eric  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 6, 2004-06 ,pp. : 489-495

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE Junction

By Malik Imtiaz   Bernal Pedro   Byrd Janet  

Cancer Investigation, Vol. 28, Iss. 8, 2010-09 ,pp. : 833-838

Informa Healthcare

Access to resources Recommend Favorite

First-Line Chemotherapy with Paclitaxel and Platinum for Advanced and Recurrent Cancer of the Cervix-A Phase II Study

By Piver M.S.   Ghamande S.A.   Eltabbakh G.H.   O'Neill-Coppola C.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 334-337

Elsevier

Access to resources Recommend Favorite

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

By Lee Jeeyun   Im Young-Hyuck   Cho Eun   Hong Yong   Lee Hyo   Kim Hyo   Kim Mi-Jin   Kim Kwhanmien   Kang Won   Park Keunchil   Shim Young  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 77-84

Springer Publishing Company

Access to resources Recommend Favorite